Clinical use of hematopoietic growth factors.
Löwenberg
B
B
Dale
D C
DC
Sheridan
W P
WP
D000208:Acute Disease; D000741:Anemia, Aplastic / Q000628:therapy; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001327:Autoimmune Diseases / Q000150:complications / Q000628:therapy; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D006085:Graft Survival / Q000187:drug effects; D015658:HIV Infections / Q000150:complications; D006402:Hematologic Diseases / Q000628:therapy*; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007951:Leukemia, Myeloid / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000628:therapy; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D014411:Neoplastic Stem Cells / Q000187:drug effects; D009503:Neutropenia / Q000139:chemically induced / Q000209:etiology / Q000628:therapy; D018121:Receptors, Cytokine / Q000502:physiology; D011994:Recombinant Proteins / Q000627:therapeutic use
D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors; D018121:Receptors, Cytokine; D011994:Recombinant Proteins